Takeda Pharmaceutical Co ADR (NYSE: TAK) is -3.71% lower on its value in year-to-date trading and has touched a low of $12.57 and a high of $15.08 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The TAK stock was last observed hovering at around $13.73 in the last trading session, with the day’s gains setting it 0.01%.
Currently trading at $13.74, the stock is 1.06% and -1.07% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.86 million and changing 0.07% at the moment leaves the stock -0.79% off its SMA200. TAK registered -2.41% loss for a year compared to 6-month gain of 1.70%. The firm has a 50-day simple moving average (SMA 50) of $13.905 and a 200-day simple moving average (SMA200) of $13.85325.
The stock witnessed a -0.87% loss in the last 1 month and extending the period to 3 months gives it a -7.72%, and is -0.87% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 1.01% over the week and 1.05% over the month.
Takeda Pharmaceutical Co ADR (TAK) has around 49281 employees, a market worth around $43.56B and $30.22B in sales. Current P/E ratio is 22.79 and Fwd P/E is 30.96. Profit margin for the company is 6.36%. Distance from 52-week low is 9.26% and -8.89% from its 52-week high. The company has generated returns on investments over the last 12 months (2.42%).
The EPS is expected to shrink by -10.87% this year.
Takeda Pharmaceutical Co ADR (TAK) Top Institutional Holders
358.0 institutions hold shares in Takeda Pharmaceutical Co ADR (TAK), with institutional investors hold 2.45% of the company’s shares. The shares outstanding are 3.17B, and float is at 3.17B with Short Float at 0.18%. Institutions hold 2.45% of the Float.
The top institutional shareholder in the company is CAPITAL RESEARCH GLOBAL INVESTORS with over 13.13 million shares valued at $169.86 million. The investor’s holdings represent 0.8366% of the TAK Shares outstanding. As of 2024-06-30, the second largest holder is MONDRIAN INVESTMENT PARTNERS LTD with 7.74 million shares valued at $108.34 million to account for 0.4932 of the shares outstanding. The other top investors are MORGAN STANLEY which holds 4.99 million shares representing 0.3178% and valued at over $64.53 million, while MILLENNIUM MANAGEMENT LLC holds 0.277 of the shares totaling 4.35 million with a market value of $56.24 million.
Takeda Pharmaceutical Co ADR (TAK) Insider Activity
#####
Takeda Pharmaceutical Co ADR disclosed in a document filed with the SEC on Jan 24 ’24 that TAKEDA PHARMACEUTICAL CO LTD (10% Owner) sold a total of 3,703,703 shares of the company’s common stock. The trade occurred on Jan 24 ’24 and was made at $8.10 per share for $30.0 million. Following the transaction, the insider now directly holds 3.76 million shares of the TAK stock.
